Han, B., Song, Y., Li, C., Yang, W., Ma, Q., Jiang, Z., . . . Gao, Q. (2021). Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: A double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infectious Diseases, 21(12), 1645-1654.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Han, Bihua, et al. "Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Healthy Children and Adolescents: A Double-blind, Randomised, Controlled, Phase 1/2 Clinical Trial."
Lancet Infectious Diseases 21, no. 12 (2021): 1645-1654.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Han, Bihua, et al. "Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Healthy Children and Adolescents: A Double-blind, Randomised, Controlled, Phase 1/2 Clinical Trial."
Lancet Infectious Diseases, vol. 21, no. 12, 2021, pp. 1645-1654.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.